Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori.

Ra SW, Sze MA, Lee EC, Tam S, Oh Y, Fishbane N, Criner GJ, Woodruff PG, Lazarus SC, Albert R, Connett JE, Han MK, Martinez FJ, Aaron SD, Reed RM, Man SFP, Sin DD. Azithromycin and risk of COPD exacerbations in patients with and without Helicobacter pylori. Respir Res. 2017 05 30; 18(1):109.

View in: PubMed

subject areas

Aged
Anti-Bacterial Agents
Antibodies, Bacterial
Azithromycin
Biomarkers
C-Reactive Protein
Disease Progression
Disease-Free Survival
Female
Helicobacter Infections
Helicobacter pylori
Humans
Kaplan-Meier Estimate
Lung
Male
Middle Aged
Proportional Hazards Models
Pulmonary Disease, Chronic Obstructive
Receptors, Tumor Necrosis Factor, Type II
Risk Factors
Serologic Tests
Time Factors
Treatment Outcome